• AMIA 2018 Annual Symposium

    Data, Technology, and Innovation for Better Health

AMIA 2018 Annual Symposium Keynotes

Opening Keynote Speaker

Sunday, November 4, 2018, 1:30 p.m. – 3:00 p.m.

Jessica L. Mega, MD, MPH, is the Chief Medical Officer at Verily Life Sciences. As CMO, Dr. Mega's focus is on translating technological innovations and scientific insights into partnerships and programs that improve patient outcomes. She oversees all of Verily's clinical and science efforts, including the Baseline Study.

As a faculty member at Harvard Medical School, a senior investigator with the TIMI Study Group, and a cardiologist at Brigham and Women’s Hospital, she led large, international, randomized trials evaluating novel cardiovascular therapies. She also directed the TIMI Study Group’s Genetics Program. Her findings have been published in the New England Journal of Medicine, Lancet, JAMA, and elsewhere. Dr. Mega sits on the advisory group for the California Governor on Precision Medicine.

Dr. Mega is a graduate of Stanford University, Yale University School of Medicine and Harvard School of Public Health. She completed Internal Medicine Residency at Brigham and Women’s Hospital and Cardiovascular Fellowship at Massachusetts General Hospital. She is board certified in Internal Medicine and Cardiology. She has won the Laennec Society, Samuel A. Levine, and Douglas P. Zipes Awards, and she is a Fellow of the American Heart Association (AHA) and the American College of Cardiology (ACC).

Closing Keynote Speakers

Wednesday, November 7, 12:30 p.m. – 1:45 p.m.

Hugo Campos is a data liberation advocate and leader in the e-patient movement. He is chair of the California Precision Medicine Consortium Community Advisory Board; participant advisor at the All of Us National Research Program; patient co-investigator for pSCANNER (Patient-Centered SCAlable National Network for Effectiveness Research); and member of the Stanford Medicine X ePatient Advisory Board. Campos is a vocal advocate for the rights of pacemaker and ICD patients to gain electronic access to their health data. In July 2015, he was honored by the White House for his advocacy work.

Larry Chu, MD, is a Professor of Anesthesiology, Perioperative and Pain Medicine and Director of the Stanford Anesthesia Informatics and Media (AIM) Lab. He is an NIH-funded clinical researcher and is Executive Director of Stanford Medicine X, the world's most-discussed academic program on emerging technology and medicine. He also directs Medicine X | ED, a conference exploring the future of patient-centered medical education. He has written eight books, over 50 papers and over 50 book chapters in academic anesthesiology and digital health. He is a member of the editorial advisory board for The BMJ, one of the most influential general medical journals in the world.

Data, Innovation and Technology for Better Health: Perspectives from Patient and Physician Partnership

In an era where society is being transformed by a booming aging population and rising health care costs, data, innovation and technology are often discussed as ways to scale care in order to meet rising demand. In this closing keynote for AMIA, Presidential Champion of Change in Precision Medicine, Hugo Campos, and Professor and Director of Medicine X, Stanford University’s program on emerging technology and medicine Larry Chu, MD, will present a joint session offering patient and physician perspectives on the importance of patients and physicians working together through partnership-enabling solutions to advance the future of healthcare.


AMIA 2018 Annual Symposium Sponsors

AMIA First Look

AMIA Working Group Supporters (NIWG)


Student Paper Prize